ISPOR's 19th Annual European meeting starts on Sunday, 10/29 in Vienna, Austria. Here is a list of presentations and discussions by our CEVR investigators:
Do first-in-class drugs offer larger incremental health gains than next-in-class drugs?
Monday, 10/31 3:45-5:45pm
James Chambers, PhD, MPharm
Emerging US Value Frameworks: Are there lessons from -or for- Europe?
Tuesday, 11/1 1:45-2:45pm
Peter Neumann, ScD
The 2nd Panel on Cost-Effectiveness for Health and Medicine will host a one-day conference highlighting their findings and recommendations. The conference will be held December 7th in Washington, DC. Click Here for registration information.
The agenda for the 2nd Panel on Cost-Effectiveness in Health and Medicine's conference is available here.
MedicalResearch.com interviewed Paige Lin, PhD to discuss her recent paper, "Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Prior to and Following Diagnosis", published online in JAGS. To read the full interview, click here.
CEA Registry update: The database now contains 5,000 studies and over 13,000 standardized cost-effectiveness ratios.